BankUnited (NYSE: BKU) (together with its subsidiaries, the “Company”)announced today the commencement of an underwritten offering of 10,307,197shares of its common stock by investment funds affiliated with TheBlackstone Group, The Carlyle Group, WL Ross & Co. LLC and CenterbridgePartners, L.P., subject to market and other conditions. BankUnited, Inc. will not receive any proceeds from the offering. Inconnection with the offering, the Selling Stockholders intend to grant theunderwriter an option to purchase an additional 1,546,079 shares in theoffering. The offering will be made pursuant to an effective shelf registrationstatement on Form S-3 filed with the Securities and Exchange Commission onMarch 6, 2013. Goldman, Sachs & Co. is acting as the sole underwriter for this offering. When available, copies of the prospectus supplement and accompanyingprospectus related to this offering may be obtained from: Goldman, Sachs &Co., Attn: Prospectus Department, 200 West Street, New York, NY 10282,telephone: 866-471-2526, facsimile: 212-902-9316, e-mail:firstname.lastname@example.org. This press release does not constitute an offer to sell or the solicitationof an offer to buy the securities, nor shall there be any sale of thesesecurities in any jurisdiction in which such offer, solicitation or salewould be unlawful prior to registration or qualification under thesecurities laws of any such jurisdiction. About BankUnited, Inc. BankUnited, Inc., a bank holding company with consolidated total assets of$15.0 billion at December 31, 2013, is the holding company of BankUnited,N.A., a national bank headquartered in Miami Lakes, Florida with 99 branchesin 15 Florida counties and 6 banking centers in the New York metropolitanarea. Forward-Looking Statements This press release contains forward-looking statements within the meaning ofthe Private Securities Litigation Reform Act of 1995 that reflect theCompany’s current views with respect to, among other things, future eventsand financial performance. The Company generally identifies forward-lookingstatements by terminology such as “outlook,” “believes,” “expects,”"potential,” “continues,” “may,” “will,” “could,” “should,” “seeks,”"approximately,” “predicts,” “intends,” “plans,” “estimates,” “anticipates”or the negative version of those words or other comparable words. Anyforward-looking statements contained in this press release are based on thehistorical performance of the Company or on the Company’s current plans,estimates and expectations. The inclusion of this forward-lookinginformation should not be regarded as a representation by the Company thatthe future plans, estimates or expectations contemplated by the Company willbe achieved. Such forward-looking statements are subject to various risksand uncertainties and assumptions relating to the Company’s operations,financial results, financial condition, business prospects, growth strategyand liquidity. If one or more of these or other risks or uncertaintiesmaterialize, or if the Company’s underlying assumptions prove to beincorrect, the Company’s actual results may vary materially from thoseindicated in these statements. These factors should not be construed asexhaustive. The Company does not undertake any obligation to publicly updateor review any forward-looking statement, whether as a result of newinformation, future developments or otherwise. A number of important factorscould cause actual results to differ materially from those indicated by theforward-looking statements including, but not limited to, the risk factorsdescribed in the prospectus supplement for the underwritten offering and theCompany’s most recent Annual Report on Form 10-K, filed with the SEC andavailable at the SEC’s website (www.sec.gov).
- UPDATE: XOMA Offers Update on Gevokizumaba, Says Results Do Not Support Movement to Pivotal Development Trial
- Market Wrap For March 4: Bulls Take Over As Ukraine Fears Dissipate
- UPDATE: Synageva Biopharma™ Announces 2M Share Proposed Public Offering of Its Common Stock
(c) 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
- Investment & Company Information